>>> Up
* Activision Blizzard Raised to Outperform at Baird; PT $95
* Air France-KLM Raised to Buy at HSBC; PT 1.70 euros
* BP Raised to Buy at Citi; PT 540 pence
* Duerr AG Reiterate with Buy at Warburg Research PT up to 37 euros from 33.50 euros (+)
* Essity Raised to Outperform at Exane
* GSK Raised to Buy at Intron Health
* Lufthansa Raised to Hold at HSBC; PT 6.75 euros
* Repsol Raised to Outperform at RBC; PT 19 euros
* SSE Raised to Outperform at RBC; PT 2,050 pence
>>> Down
* Airbnb Cut to Neutral at Baird; PT $100
* Forterra Cut to Add at Numis; PT 255 pence (+)
* Pandora Cut to Hold at HSBC; PT 540 kroner
* Seaway 7 Cut to Hold at Fearnley; PT 6 kroner (+)
* SwissRe Cut to hold from Buy at Societe Generale, PT CHF85.40 (+)
* Vantage Towers Cut to Hold at Jefferies; PT 32 euros
* Vimian Cut to Equal-Weight at Barclays
* Vodafone Cut to Underperform at Credit Suisse; PT 90 pence
* Xior Cut to Accumulate at KBC Securities
>>> Initiation
* Cellnex Rated New Hold at Mirabaud Securities; PT 36.67 euros (+)
* Colgate-Palmolive Rated New Peerperform at Wolfe
>>> Call
* Citi Sees Rotation Into Energy Stocks to Continue, Upgrades BP
* Buffett TSMC Stake Augurs 2023 Chip Stock Gains: Lombard Odier
* ConvaTec Set for Growth Acceleration, New Buy at Jefferies
* Essity Upgraded at Exane BNP With Cost Pressures Now Abating
* Goldman Says S&P 500 and Its Earnings to Change Little Next Year
* Repsol Upgraded at RBC on Benefits From Refining Exposure
* SSE Raised to Outperform at RBC on Long-Term Growth Outlook
* Verbund Shares Are ‘Ridiculously Cheap,’ Stifel Upgrades to Buy
* Vimian Downgraded at Barclays on Poor Execution Track Record (+)
* Vodafone Double-Downgraded as CS Sees Cost, Dividend Risks